Protein Related to ALS Onset Used to Develop New Method of Antibody Validation for Use in Research
Scientists have developed a new method to validate antibodies for research, demonstrating its effectiveness by using the protein encoded by the C9ORF72 gene, which, when mutated, may cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), a study reports. They also urged its implementation in labs around…